Italian Ambassador Marco Conticelli won two trophies in the 7th edition of $Diplomats & Friends" tennis tournament that completed today and took place at the tennis courts of the National Tennis Center at Knyaz-Borisova Gradina in Sofia. Ambassador Conticelli defended his single status from the previous year after outplaying the Ambassador of Denmark, Christian Kønigsfeld in the final in category "Over 50 years". The Italian added to his success the cup for first place in pairs, where his partner was Svetoslav Stankov (Ministry of Foreign Affairs).

A Bulgarian medicinal product is the most efficient device for smoking cessation. This has been announced by New Zealand scientists as a conclusion from an independent study conducted by them. They carried out a study to compare the effect of the Bulgarian Tabex® - one of the leading products in Sopharma's portfolio, and the nicotine-replacement therapy (CASCAID). The results were published in the prestigious medical journal The New England Journal of Medicine.

The European Parliament voted on 9 June 2015 in Brussels the report of Ms Mosca “Strategy for the Protection and Enforcement of Intellectual Property Rights in Third Countries” which calls on the Commission to stimulate early export of generic and biosimilar medicines to countries where no patent or supplementary protection certificates (SPC) exist.

In his inaugural speech at the 21st Annual Conference of the European Generic and Biosimilar Medicines Association (EGA), EGA President Mr Nick Haggar said that the European industry for generic and biosimilar medicines “fulfils its mission by providing high quality medicines for patients in Europe, increasing their access to effective treatment and partnering for sustainable healthcare”.

According to one of the purposes of the latest healthcare strategy, Bulgaria has to spend more public funds for medical treatment of patients with generic medicines, which are much cheaper than the original drugs. Thus, this country would be able to save a substantial amount of money. Chairman of the Board of Directors of Sopharma pharmaceutical company Ognian Donev told Radio Bulgaria that the authorities have to put more efforts into the country’s pro-generic medicine policy: “We are still waiting to see real policy in this field.

Събрахме и предадохме за каузите на проекта #bulgariacapproject

Вчера, 09.07.2015, по време на оспорваната надпревара на Европейския тенис турнир за ветерани на НТЦ беше открит иновативен еко веловръз „Здрави”. Той е първият от серия стойки за велосипеди, с която приключи „sopharmabike”, съвместен проект на Софарма, Драг и Дарик. 

Веловръзът” Здрави” е за 12 велосипеда и е поставен на тенис кортовете в Борисовата градина. 

A new study published in the journal Addiction suggests countries have no excuse for not helping their citizens quit smoking. With tobacco still the leading cause of preventable death worldwide, killing some 5 million people annually, even the poorest countries can do their part. The international team of researchers behind the study offer up six methods that are globally affordable and shown to work. 1.

Sopharma is among the 17 Bulgarian companies in the Top 500 of the international credit insurer - Coface CEE.The ranking is for the largest companies in Central and Eastern Europe and has been published for the seventh consecutive year.The Bulgarian companies for 2014 are 17 and their total turnover reached 17.99 billion euros, which is 4.24% growth. The total turnover of all companies included in the ranking is 572 billion euros. http://www.darikfinance.bg/novini/117441

The Chairman of the Board of Directors of Sopharma Ognian Donev was elected Vice-President of the Vienna Economic Forum. Thus, he will be one of the three Vice-Presidents of the President of the Organisation Mr. Erhard Busek who was Vice-Chancellor of Austria in the period of 1991-1995 and Special Co-ordinator of the Stability Pact for South-Eastern Europe in the period of 2002-2008. The Vienna Economic Forum is an organisation making its object to promote and help for the practical achievement of investments in the region from the Adriatic to the Black Sea.